These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23623008)

  • 1. Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's disease.
    Fleury V; Wider C; Horvath J; Zacharia A; Bally J; Pollak P; Pollo C; Vingerhoets FJ; Burkhard PR
    Parkinsonism Relat Disord; 2013 Jul; 19(7):707-8. PubMed ID: 23623008
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of VPS35 p.D620N mutation-related Parkinson's disease in a Taiwanese family with successful bilateral subthalamic nucleus deep brain stimulation: a case report and literature review.
    Chen YF; Chang YY; Lan MY; Chen PL; Lin CH
    BMC Neurol; 2017 Oct; 17(1):191. PubMed ID: 28985717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Zibetti M; Merola A; Rizzi L; Ricchi V; Angrisano S; Azzaro C; Artusi CA; Arduino N; Marchisio A; Lanotte M; Rizzone M; Lopiano L
    Mov Disord; 2011 Nov; 26(13):2327-34. PubMed ID: 22012750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
    Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
    Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease.
    Sako W; Nishio M; Maruo T; Shimazu H; Matsuzaki K; Tamura T; Mure H; Ushio Y; Nagahiro S; Kaji R; Goto S
    Mov Disord; 2009 May; 24(7):1076-9. PubMed ID: 19353719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A methodology to improve social adjustment after bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Meyer M; Schwan R; Colnat-Coulbois S; Lerond J; Vespignani H; Gospodaru N; Barroche G; Spitz E; Montel S
    Int J Geriatr Psychiatry; 2012 Aug; 27(8):876-8. PubMed ID: 22767448
    [No Abstract]   [Full Text] [Related]  

  • 8. Subthalamic nucleus stimulation in Parkinson's disease: the other side of the medallion.
    Temel Y
    Exp Neurol; 2008 Jun; 211(2):321-3. PubMed ID: 18410927
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute effects of bilateral subthalamic stimulation on decision-making in Parkinson's disease.
    Oyama G; Shimo Y; Natori S; Nakajima M; Ishii H; Arai H; Hattori N
    Parkinsonism Relat Disord; 2011 Mar; 17(3):189-93. PubMed ID: 21276745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast sensitivity in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.
    Chou KL; Amick MM; Gagner M
    Mov Disord; 2009 Apr; 24(5):766-9. PubMed ID: 19224590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Lanotte M; Lopiano L
    Mov Disord; 2011 Mar; 26(4):664-70. PubMed ID: 21469197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Toft M; Dietrichs E
    Mov Disord; 2014 Feb; 29(2):275-6. PubMed ID: 23696136
    [No Abstract]   [Full Text] [Related]  

  • 13. Bilateral subthalamic deep brain stimulation in Parkinson disease patients with severe tremor.
    Kim HJ; Jeon BS; Paek SH; Lee JY; Kim HJ; Kim CK; Kim DG
    Neurosurgery; 2010 Sep; 67(3):626-32; discussion 632. PubMed ID: 20647970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in blood cortisol corresponds to weight gain following deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Růžička E; Nováková L; Jech R; Urgošík D; Růžička F; Haluzík M
    Stereotact Funct Neurosurg; 2012; 90(6):410-1. PubMed ID: 23075541
    [No Abstract]   [Full Text] [Related]  

  • 15. A cost analysis of intraoperative microelectrode recording during subthalamic stimulation for Parkinson's disease.
    McClelland S
    Mov Disord; 2011 Jul; 26(8):1422-7. PubMed ID: 21674622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verbal fluency in patients receiving bilateral versus left-sided deep brain stimulation of the subthalamic nucleus for Parkinson's disease.
    Sjöberg RL; Lidman E; Häggström B; Hariz MI; Linder J; Fredricks A; Blomstedt P
    J Int Neuropsychol Soc; 2012 May; 18(3):606-11. PubMed ID: 22264411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-frequency stimulation of the subthalamic nucleus increases pallidal neuronal firing rate in a patient with Parkinson's disease.
    Reese R; Steigerwald F; Pötter M; Herzog J; Deuschl G; Volkmann J; Pinsker MO; Mehdorn HM
    Mov Disord; 2008 Oct; 23(13):1945-7. PubMed ID: 18661546
    [No Abstract]   [Full Text] [Related]  

  • 18. Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients.
    Erola T; Karinen P; Heikkinen E; Tuominen J; Haapaniemi T; Koivukangas J; Myllylä V
    Parkinsonism Relat Disord; 2005 Mar; 11(2):89-94. PubMed ID: 15734666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deep brain stimulation for Parkinson's disease].
    Date I; Matsui T
    No To Shinkei; 2004 Oct; 56(10):827-41. PubMed ID: 15609670
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of subthalamic nucleus stimulation in C9ORF72 expansion related parkinsonism.
    Danaila T; Polo G; Klinger H; Broussolle E; Mertens P; Lesage S; Brice A; Thobois S
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1104-5. PubMed ID: 25085746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.